ReviewAdvances in experimental medicine and biology2026
MS-Based Proteomics Approach in Mapping Protein-Protein Interaction.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Proteins are functional biomolecules whose modifications and activities reflect the state of health and well-being. However, while several proteins function independently, most proteins do not function in isolation but interact with other proteins within proximity, either transiently or stably at the molecular level to exert their functions. Understanding these proteins, their complexes, and interactions is a key factor in understanding molecular mechanisms in several disease-related pathways, in diagnoses, prognoses, and in the development of effective therapeutic targets. Post-translational modifications (PTMs) are the key regulators of protein-protein interactions, controlling the strength and specificity of interactions by modifying protein shape, net charge, and interaction motifs. Previously, several techniques have been employed in studying proteins, their PTMs, and PPI profiling, including yeast 2-hybrid, affinity purification, co-immunoprecipitation, proximity labeling, and crosslinking. While these techniques have been successful in mapping out thousands of both stable and transient PPIs, developments aimed at high-throughput mapping of PPIs with increased sensitivity and specificity, primarily with weakly transient interactions, would be crucial. In recent times, mass spectrometry (MS)-based proteomics approaches in tandem with bioinformatics, AI-based computational models, and other emerging tools have become central in the investigation of protein complexes and PPIs, enabling large-scale identification of protein patterns with increased sensitivity and specificity. With the sensitivity and robustness of MS and the automation and optimization of proteomics workflows, this development opens the door for the verification and validation of identified PPIs, and the high-throughput determination of novel PPIs and protein complex functions, thereby unraveling undiscovered pathogenic mechanisms.
Indexed as
Identifiers
42907649What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.